4 news items
Johnson & Johnson To Acquire Early-Stage Eczema Treatment Developer Proteologix For $850M
JNJ
SWAV
16 May 24
Therapeutic Area Head, Johnson & Johnson Innovative Medicine
In addition to PX128 and PX130, the acquisition will provide J&J with other
Shockwave Reducer Demonstrates Consistent, Positive Results in 'Real-World' Study
SWAV
8 Apr 24
in the development and commercialization of innovative products that are transforming the treatment of cardiovascular disease. Its first-of-its-kind
Johnson & Johnson to Acquire Shockwave Medical
JNJ
SWAV
5 Apr 24
Extends Johnson & Johnson MedTech's Position in Highest-Growth, Innovation-Oriented Segments
Shockwave Medical to Participate in the 23rd Annual Needham Virtual Healthcare Conference
SWAV
26 Mar 24
Shockwave Medical, Inc. Shockwave Medical is a leader in the development and commercialization of innovative products
- Prev
- 1
- Next